IRCT201510031475N8已完成3 期
Randomized, double blind, phase 3 clinical trial of ?efficacy and safety of radio wave-induced heat therapy ?plus topical liposomal Amphotericin B in comparison ?with heat therapy plus placebo for the treatment of ?zoonotic cutaneous leishmaniasis caused by ?Leishmania major ??
ational Institute for Medical Research Development (NIMAD)0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 years 至 60 years（—）
- 性别
- All
入选标准
- •Males & females 12-60 years of age;Parasitologically proven CL caused by L. major (identification is done ?by using PCR); Otherwise healthy subjects on the basis of medical history; physical ?examination and results of blood test if requested by the physician; Ability to understand the principles of the trial and Signing an ?informed consent voluntarily and knowingly.?
排除标准
- •Pregnant or lactating women; Concurrent or chronic illness based on previous history;Duration of lesion more than 3 months;Number of lesions more than 5;Ulcer size greater than 3 cm in their largest diameter; History of full course of standard treatment (antimonials); ?Involvement in any other drug or vaccine trial during the study period.?
研究者
相似试验
进行中（未招募）
3 期
Randomized, double-blind, phase III clinical study to evaluate the immunogenicity of an influenza vaccine with adjuvant in health personnel (EDUCATE)J10 NULLPER-015-21PERUVIAN CLINICAL RESEARCH S.A.C.274
进行中（未招募）
1 期
MS-STAT2 - Multiple Sclerosis – Simvastatin Trial 2Multiple sclerosisEUCTR2017-003328-56-GBniversity College London Comprehensive Clinical Trials Unit1,180
未知
不适用
Study with methyl salicylate 30 g to evaluate the safety and effectiveness of methyl salicylate 30 g and 1 g benzocaine ointment as an adjunct in the treatment of knee osteoarthritis and musculoskeletal pain.PER-036-13ABORATORIOS FARMASUR S.A.C.,
已完成
3 期
Efficacy of topical nano-liposomal Amphotericin B in the treatment of cutaneous leishmaniasis caused by L. majorCutaneous Leishmaniasis.Cutaneous leishmaniasisIRCT201510161475N10Iran Nanotechnology, Inititave concil110
已完成
3 期
Double blind, randomized phase 3 efficacy trial of topical nano-liposomal paromomycin in the treatment of cutaneous leishmaniasis caused by L. majorCutaneous leishmaniasis otherwise Healthy.minor skin diseaseIRCT201108301475N6Center for Research & Training in Skin Diseases & Leprosy Tehran University of Medical Sciences; Dis144